Folic Acid Functionalized Diallyl Trisulfide-Solid Lipid Nanoparticles for Targeting Triple Negative Breast Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | De, Anindita | - |
dc.contributor.author | Roychowdhury, Parikshit | - |
dc.contributor.author | Bhuyan, Nihar Ranjan | - |
dc.contributor.author | Ko, Young Tag | - |
dc.contributor.author | Singh, Sachin Kumar | - |
dc.contributor.author | Dua, Kamal | - |
dc.contributor.author | Kuppusamy, Gowthamarajan | - |
dc.date.accessioned | 2023-05-17T02:52:54Z | - |
dc.date.available | 2023-05-17T02:52:54Z | - |
dc.date.created | 2023-05-08 | - |
dc.date.issued | 2023-02 | - |
dc.identifier.issn | 1420-3049 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/87858 | - |
dc.description.abstract | DATS (diallyl trisulfide), an anti-oxidant and cytotoxic chemical derived from the plant garlic, has been found to have potential therapeutic activity against triple-negative breast cancer (TNBC). Its hydrophobicity, short half-life, lack of target selectivity, and limited bioavailability at the tumor site limit its efficacy in treating TNBC. Overexpression of the Folate receptor on the surface of TNBC is a well-known target receptor for overcoming off-targeting, and lipid nanoparticles solve the limitations of limited bioavailability and short half-life. In order to overcome these constraints, we developed folic acid (FA)-conjugated DATS-SLNs in this research. The design of experiment (DoE) method was employed to optimize the FA-DATS-SLNs' nanoformulation, which resulted in a particle size of 168.2 +/- 3.78 nm and a DATS entrapment of 71.91 +/- 6.27%. The similarity index between MCF-7 and MDA-MB-231 cell lines demonstrates that FA-DATS-SLNs are more therapeutically efficacious in the treatment of aggravating TNBC. Higher cellular internalization and efficient Bcl2 protein downregulation support the hypothesis that functionalization of the FA on the surface of DATS-SLNs improves anticancer efficacy when compared with DATS and DATS-SLNs. FA-functionalized DATS-SLNs have demonstrated to be a promising therapeutic strategy for TNBC management. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | MOLECULES | - |
dc.title | Folic Acid Functionalized Diallyl Trisulfide-Solid Lipid Nanoparticles for Targeting Triple Negative Breast Cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000933751700001 | - |
dc.identifier.doi | 10.3390/molecules28031393 | - |
dc.identifier.bibliographicCitation | MOLECULES, v.28, no.3 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85147934121 | - |
dc.citation.title | MOLECULES | - |
dc.citation.volume | 28 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | De, Anindita | - |
dc.contributor.affiliatedAuthor | Ko, Young Tag | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | diallyl tri-sulfide | - |
dc.subject.keywordAuthor | folic acid | - |
dc.subject.keywordAuthor | solid lipid nanoparticles | - |
dc.subject.keywordAuthor | TNBC | - |
dc.subject.keywordAuthor | cellular internalization and cell migration | - |
dc.subject.keywordAuthor | Bcl2 apoptosis protein | - |
dc.subject.keywordPlus | DISULFIDE | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | DESIGN | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.